These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5057092)

  • 1. Glycosphingolipids in cultured human skin fibroblasts. II. Characterization and metabolism in fibroblasts from patients with inborn errors of glycosphingolipid and mucopolysaccharide metabolism.
    Dawson G; Matalon R; Dorfman A
    J Biol Chem; 1972 Sep; 247(18):5951-8. PubMed ID: 5057092
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycosphingolipids in cultured human skin fibroblasts. I. Characterization and metabolism in normal fibroblasts.
    Dawson G; Matalon R; Dorfman A
    J Biol Chem; 1972 Sep; 247(18):5944-50. PubMed ID: 5057091
    [No Abstract]   [Full Text] [Related]  

  • 3. G M1 -gangliosidosis (Type II): studies on a fibroblast cell strain.
    Callahan JW; Pinsky L; Wolfe LS
    Biochem Med; 1970 Nov; 4(3):295-316. PubMed ID: 4257450
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantity and fatty acyl composition of the glycosphingolipids of Gaucher spleen.
    Kuske TT; Rosenberg A
    J Lab Clin Med; 1972 Oct; 80(4):523-9. PubMed ID: 4342231
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biochemical aspects of sphingolipidosis].
    Douste-Blazy L; Thouvenot JP
    Ann Biol Clin (Paris); 1972; 30(6):623-35. PubMed ID: 4569435
    [No Abstract]   [Full Text] [Related]  

  • 6. Further developments in studies in sphingolipidoses: "missing enzymes".
    Brady RO
    Riv Patol Nerv Ment; 1970 Oct; 91(5):263-73. PubMed ID: 5525771
    [No Abstract]   [Full Text] [Related]  

  • 7. Correction of the enzymic defect in cultured fibroblasts from patients with Fabry's disease: treatment with purified alpha-galactosidase from ficin.
    Dawson G; Matalon R; Li YT
    Pediatr Res; 1973 Aug; 7(8):684-90. PubMed ID: 4732107
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sphingolipidosis].
    Juif JC
    Arch Fr Pediatr; 1971 Nov; 28(9):909-14. PubMed ID: 5144692
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sphingolipidoses. Biochemistry and enzymatic mechanisms].
    Gajdos A
    Nouv Presse Med; 1972 Jun; 1(26):1789-92. PubMed ID: 5054020
    [No Abstract]   [Full Text] [Related]  

  • 10. [Disorders of lipid metabolism--sphingolipidoses].
    Taketomi T
    Shinkei Kenkyu No Shimpo; 1971; 15(2):350-8. PubMed ID: 4999431
    [No Abstract]   [Full Text] [Related]  

  • 11. Glycopeptide storage in fibroblasts from patients with inborn errors of glycoprotein and glycosphingolipid catabolism.
    Tsay GC; Dawson G
    Biochem Biophys Res Commun; 1975 Apr; 63(3):807-14. PubMed ID: 1131265
    [No Abstract]   [Full Text] [Related]  

  • 12. Generalized accumulation of neutral glycosphingolipids with G M2 ganglioside accumulation in the brain.
    Snyder PD; Krivit W; Sweeley CC
    J Lipid Res; 1972 Jan; 13(1):128-36. PubMed ID: 5059190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid mucopolysaccharides in cultured human fibroblasts.
    Matalon R; Dorfman A
    Lancet; 1969 Oct; 2(7625):838-41. PubMed ID: 4186295
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of glycosphingolipids in small samples of human tissue.
    Dawson G
    Ann Clin Lab Sci (1971); 1972; 2(4):274-84. PubMed ID: 5072682
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of heterozygous carriers of lipid storage diseases. Current status and clinical applications.
    Brady RO; Johnson WG; Uhlendorf BW
    Am J Med; 1971 Oct; 51(4):423-31. PubMed ID: 5155766
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the glycosphingolipids of normal and virally transformed 3T3 mouse fibroblasts.
    Yogeeswaran G; Sheinin R; Wherrett JR; Murray RK
    J Biol Chem; 1972 Aug; 247(16):5146-8. PubMed ID: 4341540
    [No Abstract]   [Full Text] [Related]  

  • 17. Fabry's disease (ceramide trihexosidase deficiency): diagnostic confirmation by analysis of dental pulp.
    Desnick SJ; Witkop CJ; Krivit W; Thies JK; Desnick RJ
    Arch Oral Biol; 1972 Oct; 17(10):1473-9. PubMed ID: 4507778
    [No Abstract]   [Full Text] [Related]  

  • 18. Glycosphingolipid levels in an unusual neurovisceral storage disease characterized by lactosylceramide galactosyl hydrolase deficiency: lactosylceramidosis.
    Dawson G
    J Lipid Res; 1972 Mar; 13(2):207-19. PubMed ID: 5016302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme replacement in Fabry disease: treatment of cultured skin fibroblasts with a purified alpha-galactosidase from ficin.
    Dawson G; Matalon R; Li YT
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):97-101. PubMed ID: 4215480
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence for a terminal -D-galactopyranosyl residue in galactosylgalactosylglucosylceramide from human kidney.
    Clarke JT; Wolfe LS; Perlin AS
    J Biol Chem; 1971 Sep; 246(18):5563-9. PubMed ID: 5096082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.